Johnson & Johnson (NYSE:
JNJ) says "still more work to do on Japan operations... seeing sequential improvements from yr-ago... `making good progress' in Mcneil... 2011 sales $65.5b including currency impact... dividend remains priority."
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
